Literature DB >> 23598537

DPP-IV inhibitor-associated arthralgias.

Tira Chaicha-Brom, Tahira Yasmeen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23598537     DOI: 10.4158/EP13076.LT

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


× No keyword cloud information.
  5 in total

Review 1.  Dipeptidyl Peptidase (DPP)-4 Inhibitor-Induced Arthritis/Arthralgia: A Review of Clinical Cases.

Authors:  Annamaria Mascolo; Concetta Rafaniello; Liberata Sportiello; Maurizio Sessa; Daniela Cimmaruta; Francesco Rossi; Annalisa Capuano
Journal:  Drug Saf       Date:  2016-05       Impact factor: 5.606

Review 2.  Cardiovascular safety of therapies for type 2 diabetes.

Authors:  Puneet Gupta; William B White
Journal:  Expert Opin Drug Saf       Date:  2016-10-11       Impact factor: 4.250

3.  DPP-4 INHIBITORS INCREASE THE INCIDENCE OF ARTHRITIS/ARTHRALGIA BUT DO NOT AFFECT AUTOIMMUNITY.

Authors:  Z A Sayiner; B Okyar; B Kısacık; E Akarsu; M Özkaya; M Araz
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Oct-Dec       Impact factor: 0.877

4.  Comparative risk of musculoskeletal adverse reactions among new users of dipeptidyl peptidase-4 inhibitors: A retrospective cohort study.

Authors:  Taehwan Park; Maureen Bresnahan; Scott K Griggs; Jiajing Chen; Alex H Cho; Yolene Gousse; Mark Feinglos
Journal:  Explor Res Clin Soc Pharm       Date:  2021-05-05

Review 5.  GLP-1 Analogs and DPP-4 Inhibitors in Type 2 Diabetes Therapy: Review of Head-to-Head Clinical Trials.

Authors:  Matthew P Gilbert; Richard E Pratley
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-03       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.